Biomarkers and Tools for Predicting Alzheimer’s Disease in the Preclinical Stage

Alzheimer’s disease (AD) is the only leading cause of death for which no disease-modifying therapy is currently available. Over the past decade, a string of disappointing clinical trial results has forced us to shift our focus to the preclinical stage of AD, which represents the most promising thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tao-Ran, Yang, Qin, Hu, Xiaochen, Han, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878962/
https://www.ncbi.nlm.nih.gov/pubmed/34030620
http://dx.doi.org/10.2174/1570159X19666210524153901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878962/
https://www.ncbi.nlm.nih.gov/pubmed/34030620
http://dx.doi.org/10.2174/1570159X19666210524153901

Ejemplares similares